Serotonin syndrome is an acute clinical condition caused by excessive activity of serotonin in the central and peripheral nervous system. It ranges from mild, self‑limited symptoms to a life‑threatening emergency. The syndrome typically appears rapidly after a change in medication, the addition of another serotonergic agent, or following an overdose.
Common features and clinical picture
Patients with serotonin syndrome present with a combination of three types of abnormalities: altered mental state, autonomic instability, and neuromuscular hyperactivity. Typical complaints include agitation, confusion, headache, and anxiety. Autonomic signs can include rapid heart rate, high blood pressure, dilated pupils, sweating, and fever. Neuromuscular findings often consist of tremor, hyperreflexia, clonus (especially inducible or spontaneous ankle clonus), and muscle rigidity. Symptoms usually develop within hours of exposure and can progress quickly.
Causes and drug classes involved
The syndrome results from increased serotonergic transmission and most often follows drug interactions or overdose. Many medication classes are implicated; common examples include:
- Antidepressants (for example, selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors, and monoamine oxidase inhibitors).
- Certain opioids that have serotonergic properties or interact with other serotonergic drugs.
- Central nervous system stimulants and some appetite suppressants.
- Serotonin receptor agonists (such as some 5‑HT1 agents used for migraine).
- Psychedelic substances and illicit drugs with serotonergic effects.
- Herbal or over‑the‑counter supplements that affect serotonin, for example St. John’s wort and others, particularly when combined with prescription drugs.
Diagnosis and distinguishing features
There is no single laboratory test for serotonin syndrome; diagnosis is clinical. Several diagnostic criteria sets exist and clinicians often use recognized frameworks to assess the likelihood of the syndrome based on history and physical signs. Key distinguishing features include prominent hyperreflexia and clonus, which help separate serotonin syndrome from conditions with overlapping features such as neuroleptic malignant syndrome, anticholinergic toxicity, severe sepsis, or malignant hyperthermia.
Treatment and prognosis
Immediate management begins with stopping all serotonergic medications and providing supportive care. Mild cases may resolve after discontinuation of the offending agent and observation. For more pronounced symptoms, treatments include aggressive cooling and hydration for hyperthermia, benzodiazepines to control agitation and tremor, and in some cases administration of a serotonin antagonist such as cyproheptadine. Severe cases require intensive care with airway support, sedation, and close hemodynamic monitoring. With prompt recognition and treatment, most patients recover fully, but delays in care can lead to complications or death.
Prevention and notable facts
Preventive measures focus on careful prescribing, avoiding hazardous drug combinations, and educating patients about interactions with over‑the‑counter medications and supplements. The condition became recognized as antidepressant and serotonergic therapies were introduced and combined in clinical practice; awareness has improved diagnosis and reduced risk. When in doubt, early clinical assessment and discontinuation of suspected agents are critical steps to limit harm.